From Concept to Clinic: Advancing Novel Mechanisms & Regenerative Approaches in IPF as an Emerging Biotech
- Sharing the journey of progressing a novel therapeutic concept into the clinic in IPF as a startup, including key scientific, operational, and funding challenges faced when building a program in a high-risk, high-reward disease area
- Exploring the shift beyond traditional antifibrotic approaches toward repair and regeneration-focused strategies, and the critical considerations when developing therapies targeting novel, and not yet widely validated, mechanisms
- Translating cross-disease learnings into IPF clinical development, including how prior experience in other respiratory indications has informed trial design, endpoint selection, and strategies to demonstrate early signals of efficacy